North America Ocular Drug Delivery Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Ocular Drug Delivery Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Ocular Drug Delivery Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Ocular Drug Delivery Market Regional Analysis

6.2 North America Ocular Drug Delivery Market Revenue 2019-2028 (US$ Million)

6.3 North America Ocular Drug Delivery Market Forecast Analysis

7. North America Ocular Drug Delivery Market Analysis – by Technology

7.1 Implantable Ocular Drug Delivery Systems

7.1.1 Overview
7.1.2 Implantable Ocular Drug Delivery Systems: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Particulate Drug Delivery Systems

7.2.1 Overview
7.2.2 Particulate Drug Delivery Systems: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Nano-Particle Drug Delivery System

7.3.1 Overview
7.3.2 Nano-Particle Drug Delivery System: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Ocular Drug Delivery Market Analysis – by Formulation Type

8.1 Liposomes and Nanoparticles

8.1.1 Overview
8.1.2 Liposomes and Nanoparticles: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Solution

8.2.1 Overview
8.2.2 Solution: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Emulsion

8.3.1 Overview
8.3.2 Emulsion: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Suspension

8.4.1 Overview
8.4.2 Suspension: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Ointment

8.5.1 Overview
8.5.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Ocular Drug Delivery Market Analysis – by Disease Type

9.1 Glaucoma

9.1.1 Overview
9.1.2 Glaucoma: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Diabetic Retinopathy

9.2.1 Overview
9.2.2 Diabetic Retinopathy: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Dry Eye Syndrome

9.3.1 Overview
9.3.2 Dry Eye Syndrome: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Macular Degeneration

9.4.1 Overview
9.4.2 Macular Degeneration: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Cataract

9.5.1 Overview
9.5.2 Cataract: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.6 Diabetic Macular Edema

9.6.1 Overview
9.6.2 Diabetic Macular Edema: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Ocular Drug Delivery Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Ophthalmic Clinics

10.2.1 Overview
10.2.2 Ophthalmic Clinics: North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Ambulatory Surgical Centers

10.3.1 Overview
10.3.2 Ambulatory Surgical Centers : North America Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. North America Ocular Drug Delivery Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Ocular Drug Delivery Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 North America Ocular Drug Delivery Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.1.2 US: North America Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.1.3 US: North America Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.1.4 US: North America Ocular Drug Delivery Market Breakdown, by End User

11.2.1.2 Canada: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.2.2 Canada: North America Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.2.3 Canada: North America Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.2.4 Canada: North America Ocular Drug Delivery Market Breakdown, by End User

11.2.1.3 Mexico : North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.3.2 Mexico : North America Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.3.3 Mexico : North America Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.3.4 Mexico : North America Ocular Drug Delivery Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Novartis AG

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Clearside Biomedical, Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Ocular Therapeutix, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Envisia Therapeutics

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Alimera Sciences, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 EYEGATE PHARMACEUTICALS, INC

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Ocular Drug Delivery Market